Skip to main content

Table 4 Differentially expressed genes

From: Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft models

Entrez ID Probe name Gene name Encoded protein Log2-fold difference Adjusted p-value (false discovery rate)
5321 A_23_P11685 PLA2G4A Phospholipase A2, group IV A 6.4 4.4E-16
55349 A_23_P69293 CHDH Choline dehydrogenase 3.3 4.0E-13
1757 A_24_P35400 SARDH Sarcosine dehydrogenase 2.5 7.6E-12
9468 A_24_P941353 PCYT1B Phosphate cytidylyltransferase 1, choline, beta 1.7 3.7E-9
31896 A_23_P87401 GDPD5 Glycerophosphodiester phosphodiesterase domain containing 5 1.0 4.2E-6
8681 A_23_P403424 PLA2G4B Phospholipase A2, group IV B 0.9 9.8E-5
9791 A_23_P168868 PTDSS1 Phosphatidylserine synthase I 0.9 9.6E-7
10434 A_23_P19192 LYPLA1 Lysophospholipase 1 0.9 0.001
3931 A_23_P218237 LCAT Lecithin-cholesterol acyltransferase 0.8 0.0002
151056 A_23_P56356 PLB1 Phospholipase B1 0.7 0.0001
5337 A_23_P155335 PLD1 Phospholipase D1 0.7 0.0005
  1. Genes directly involved in choline metabolism with significantly higher expression in basal-like (MAS98.12) than luminal-like (MAS98.06) tumors